Skip to main content

Friedberg Albert's Form 4 filing

Vaccinex, Inc. (VCNX) · filed Oct 5, 2023

Accession no.
0001062993-23-019061
Filed
Oct 5, 2023, 4:30 PM ET
Trade date
Oct 3, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $3.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Friedberg AlbertCIK 0001268239Director, 10% Owner
FCMI Parent Co.CIK 000167825810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 3, 2023Common StockPPurchaseAcquired+3,000,000$1.00+$3,000,0004,747,794Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 3, 2023Common StockPPurchaseAcquired+3,000,000$1.00+$3,000,0003,000,000Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)